Barinthus Biotherapeutics (BRNS) Other Gross PP&E Adjustments (2020 - 2025)
Barinthus Biotherapeutics (BRNS) has disclosed Other Gross PP&E Adjustments for 6 consecutive years, with -$3.5 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Other Gross PP&E Adjustments rose 59.54% year-over-year to -$3.5 million, compared with a TTM value of -$3.5 million through Sep 2025, up 59.54%, and an annual FY2024 reading of $11.0 million, up 50.45% over the prior year.
- Other Gross PP&E Adjustments was -$3.5 million for Q3 2025 at Barinthus Biotherapeutics, up from -$4.3 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $11.0 million in Q4 2024 and bottomed at -$10.0 million in Q2 2022.
- Average Other Gross PP&E Adjustments over 5 years is -$4.8 million, with a median of -$7.8 million recorded in 2024.
- The sharpest move saw Other Gross PP&E Adjustments plummeted 257.33% in 2022, then soared 1537.98% in 2023.
- Year by year, Other Gross PP&E Adjustments stood at -$6.4 million in 2021, then skyrocketed by 107.0% to $445000.0 in 2022, then skyrocketed by 1537.98% to $7.3 million in 2023, then skyrocketed by 50.45% to $11.0 million in 2024, then plummeted by 132.28% to -$3.5 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for BRNS at -$3.5 million in Q3 2025, -$4.3 million in Q2 2025, and -$4.3 million in Q1 2025.